Seana Carson - 29 Feb 2024 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Signature
/s/ Brianna M. Cetrulo, attorney-in-fact
Issuer symbol
BHC
Transactions as of
29 Feb 2024
Net transactions value
-$301,631
Form type
4
Filing time
04 Mar 2024, 16:16:00 UTC
Previous filing
05 Dec 2023
Next filing
09 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +147,536 +39% $0.000000 530,461 29 Feb 2024 Direct F1
transaction BHC Common Shares, No Par Value Tax liability $7,566 -765 -0.14% $9.89 529,696 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability $59,281 -5,994 -1.1% $9.89 523,702 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability $167,863 -16,973 -3.2% $9.89 506,729 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability $5,054 -511 -0.1% $9.89 506,218 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Sale $43,316 -4,420 -0.87% $9.80 501,798 04 Mar 2024 Direct F3
transaction BHC Common Shares, No Par Value Sale $1,950 -199 -0.04% $9.80 501,599 04 Mar 2024 Direct F3
transaction BHC Common Shares, No Par Value Sale $15,298 -1,561 -0.31% $9.80 500,038 04 Mar 2024 Direct F3
transaction BHC Common Shares, No Par Value Sale $1,303 -133 -0.03% $9.80 499,905 04 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F3 Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023.